Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Oct 6;17(1):415.
doi: 10.1186/s12891-016-1264-8.

The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol

Linda S Chesterton  1 , Krysia S Dziedzic  2 , Danielle A van der Windt  2 , Graham Davenport  2 , Helen L Myers  2 , Trishna Rathod  2 , Milica Blagojevic-Bucknall  2 , Sue M Jowet  2 , Claire Burton  2 , Edward Roddy  2 , Elaine M Hay  2
Affiliations
Randomized Controlled Trial

The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol

Linda S Chesterton et al. BMC Musculoskelet Disord. .

Abstract

Background: Patients diagnosed with idiopathic mild to moderate carpal tunnel syndrome (CTS) are usually managed in primary care and commonly treated with night splints and/or corticosteroid injection. The comparative effectiveness of these interventions has not been reliably established nor investigated in the medium and long term. The primary objective of this trial is to investigate whether corticosteroid injection is effective in reducing symptoms and improving hand function in mild to moderate CTS over 6 weeks when compared with night splints. Secondary objectives are to determine specified comparative clinical outcomes and cost effectiveness of corticosteroid injection over 6 and 24 months.

Method/design: A multicentre, randomised, parallel group, clinical pragmatic trial will recruit 240 adults aged ≥18 years with mild to moderate CTS from GP Practices and Primary-Secondary Care Musculoskeletal Interface Clinics. Diagnosis will be by standardised clinical assessment. Participants will be randomised on an equal basis to receive either one injection of 20 mg Depo-Medrone or a night splint to be worn for 6 weeks. The primary outcome is the overall score of the Boston Carpal Tunnel Questionnaire (BCTQ) at 6 weeks. Secondary outcomes are the BCTQ symptom severity and function status subscales, symptom intensity, interrupted sleep, adherence to splinting, perceived benefit and satisfaction with treatment, work absence and reduction in work performance, EQ-5D-5L, referral to surgery and health utilisation costs. Participants will be assessed at baseline and followed up at 6 weeks, 6, 12 and 24 months. The primary analysis will use an intention to treat (ITT) approach and multiple imputation for missing data. The sample size was calculated to detect a 15 % greater improvement in the BTCQ overall score in the injection group compared to night-splinting at approximately 90 % power, 5 % two-tailed significance and allows for 15 % loss to follow-up.

Discussion: The trial makes an important contribution to the evidence base available to support effective conservative management of CTS in primary care. No previous trials have directly compared these treatments for CTS in primary care populations, reported on clinical effectiveness at more than 6 months nor compared cost effectiveness of the interventions.

Trial registration: Trial registration: EudraCT 2013-001435-48 (registered 05/06/2013), ClinicalTrials.gov NCT02038452 (registered 16/1/2014), and Current Controlled Trials ISRCTN09392969 (retrospectively registered 01/05/2014).

Keywords: Boston Carpal Tunnel Questionnaire; Carpal Tunnel Syndrome; Corticosteroid injection; Night splints; Protocol; Randomised clinical trial.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow of participants through the trial
See this image and copyright information in PMC

References

    1. Phalen GS. The carpal-tunnel syndrome. Seventeen years’ experience in diagnosis and treatment of six hundred fifty-four hands. J Bone Joint Surg Am. 1966;48(2):211–28. - PubMed
    1. Dziedzic K, Thomas E, Hill S, Wilkie R, Peat G, Croft PR. The impact of musculoskeletal hand problems in older adults: findings from the North Staffordshire Osteoarthritis Project (NorStOP) Rheumatology (Oxford) 2007;46(6):963–7. doi: 10.1093/rheumatology/kem005. - DOI - PubMed
    1. Hill S, Dziedzic K, Thomas E, Baker SR, Croft P. The illness perceptions associated with health and behavioural outcomes in people with musculoskeletal hand problems: findings from the North Staffordshire Osteoarthritis Project (NorStOP) Rheumatology (Oxford) 2007;46(6):944–51. doi: 10.1093/rheumatology/kem015. - DOI - PubMed
    1. Spies-Dorgelo MN, van der Windt DA, van der Horst HE, Prins AP, Stalman WA. Hand and wrist problems in general practice--patient characteristics and factors related to symptom severity. Rheumatology (Oxford) 2007;46(11):1723–8. doi: 10.1093/rheumatology/kem253. - DOI - PubMed
    1. Bland JDP, Rudolfer SM. Clinical surveillance of carpal tunnel syndrome in two areas of the United Kingdom, 1991–2001. J Neurol Neurosurg Psychiatry. 2003;74(12):1674–9. doi: 10.1136/jnnp.74.12.1674. - DOI - PMC - PubMed

MeSH terms